Inflation rebates to reduce Medicare payment for 34 Part B drugs

This October through December under the Inflation Reduction Act, Medicare will reduce the beneficiary coinsurance amount for 34 Part B prescription drugs between $1 and $618 per average dose, the Centers for Medicare & Medicaid Services announced recently.

The Build Back Better (BBB) Act: Detailed Summary of Medicare

Inflation Reduction Act Rebates: Changes to Medicare

Inflation Reduction Act's Medicare Part B and D inflation rebates

A Comparison of Brand-Name Drug Prices Among Selected Federal

Drug Companies Continue To Hike Prices Above Inflation - Center

Costs of 34 Medicare Drugs Capped at $618 Until December

How Changes to Medicare Part D Will Impact Federal Annuitants

News ASHE

The Inflation Reduction Act: Implementation of the Medicare